• About KNI

    KNI entry

    The Kentucky Neuroscience Institute integrates the expertise of UK neurology and neurosurgery physicians and researchers. KNI is a regional referral center dedicated to providing comprehensive care to our patients.


  • Advanced technologies

    KNI offers patients the benefits of Gamma Knife® therapy. It is one of the most precise, powerful and proven treatments for brain and spinal cord tumors. Gamma Knife therapy does not involve surgery. Instead, it focuses precise beams of radiation directly on a tumor.

    Additionally, we are the region's only Level IV Epilepsy Center. Our Epilepsy Monitoring Unit (EMU) is a dedicated six-bed unit with the latest diagnostic monitoring equipment to accurately diagnose the causes of epileptic seizures, allowing physicians to create a more accurate treatment plan. The Kentucky Neuroscience Institute also offers the latest advancements in minimally invasive surgery, such as kyphoplasty and other spine procedures, which allows patients to recover much faster.
     

  • UK Neurology appointments

    Phone (for all neurology calls)

    859-323-5661  

    Hours

    Monday - Friday
    8 a.m. - 5 p.m.

    Request an appointment online » 

    Most commonly, patients are referred through their primary care provider or neurologist.

  • Kentucky Neuroscience Institute in the news

    UK is first in the U.S. to conduct trial of new Parkinson’s disease treatment. A clinical trial being conducted at UK is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment of the disease and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.

    Progress in Parkinson's care

    Craig van Horne, MD, associate professor of neurosurgery in the College of Medicine and principal investigator of the clinical trial, came to the Kentucky Neuroscience Institute only two years ago, but he is already making significant contributions to research and patient care related to Parkinson’s disease. If successful, this procedure could significantly change the treatment of Parkinson’s disease and could have an impact on other neurodegenerative disorders as well. Learn more.

  • Quality achievement award

    stroke award 2016

    UK HealthCare’s Kentucky Neuroscience Institute (KNI) has received the Get With The Guidelines – Stroke Gold-Plus Quality Achievement Award by the American Heart Association/American Stroke Association for maintaining nationally recognized standards for the treatment of stroke patients. Learn more about the Stroke Gold Plus Quality Achievement Award »



    Leading-edge comprehensive stroke care

    Stroke patients at the Kentucky Neuroscience Institute have access not only to the region's top doctors, but also to the most advanced medical technology. The stroke center at UK Chandler Hospital was the first in the region to be designated as a  Comprehensive Stroke Center.

    DSC AHA comprehensive stroke logo 

  • Treatments Available for Drug-Resistant Epilepsy

    UK HealthCare is No. 1 in Kentucky in Latest U.S. News Best Hospitals Rankings

    ALS Patient Advocate Hopes Free Screening of Documentary Will Inspire Others

    Patient Turned Advocate Inspires Fundraiser for Parkinson's Research

    KNI Stroke Center Receives High Designation from American Heart Association

    13-Year-Old Boy Enjoys Being “Normal Kid" Again After Epilepsy Surgery

    Goldstein Drafts Editorial on Carotid Artery Screening for JAMA Internal Medicine

    Two UK Faculty Help Draft Policy Statement for the American Heart Association

    Conference to Highlight Changes in the Neurology and Neurosurgery Fields

    Conference to Highlight Changes in the Neurology and Neurosurgery Fields

    UK HealthCare Regains Prestigious Magnet Recognition for Excellence in Patient Care

    Dobbs Appointed to Editorial Position for Prestigious National Journal

    Stroke is a "Woman's Disease"

    KNI Re-designated a Comprehensive Stroke Center by The Joint Commission

    NINDS Director Discusses "The Brain Initiative" at Grand Rounds